克拉拉細胞蛋白16(CC16)重組蛋白
Recombinant Clara Cell Protein 16 (CC16)
SCGB1A1; CC10; CCSP; UGB; UG; Uteroglobin; Uteroglobin; Urinary Protein 1; Clara Cell Secretory Protein; Secretoglobin Family 1A Member 1; Clara-Cell Specific 10-kD Protein
- 編號RPA857Ra01
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量9.8kDa
- 實際分子量10kDa(差異分析請參閱說明書)
- 片段與標簽Asp22~Val96 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點4.4
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1008 ¥ 2520 ¥ 5040 ¥ 15120 ¥ 37800
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| APA857Ra01 | 克拉拉細胞蛋白16(CC16)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA857Ra01 | 克拉拉細胞蛋白16(CC16)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA857Ra01 | 克拉拉細胞蛋白16(CC16)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA857Ra71 | 克拉拉細胞蛋白16(CC16)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAA857Ra81 | 克拉拉細胞蛋白16(CC16)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| MAA857Ra21 | 克拉拉細胞蛋白16(CC16)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA857Ra | 克拉拉細胞蛋白16(CC16)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA857Ra | 克拉拉細胞蛋白16(CC16)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
| KSA857Ra01 | 克拉拉細胞蛋白16(CC16)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Life Science Journal | Pulmonary functions and blood biochemical markers for workers with and without coal worker pneumoconiosis [Sciencepub: Source] |
| Current Therapeutic Research | Analysis of the Protective Biochemical and Pathologic Effects of Aminoguanidine on an Experimental Aspiration Pneumonitis Model Induced by Bile Acids [PubMed: S0011393X12000562] |
| J Thorac Dis. | Effects of leflunomide on inflamation and fibrosis in bleomycine induced pulmonary fibrosis in wistar albino rats [Pubmed: 24255778] |
| J Mol Histol. | The therapeutic effects of anti-oxidant and anti-inflammatory drug quercetin on aspiration-induced lung injury in rats [Pubmed: 24122261] |
| Hum Exp Toxicol January | The effects of α-tocopherol on oxidative damage and serum levels of Clara cell protein 16 in aspiration pneumonitis induced by bile acids [Pubmed: 23023024] |
| Journal of Thoracic Disease | The evaluation of different treatment protocols for trauma-induced lung injury in rats [Pubmed: 24605218] |
| PLOS ONE | Susceptibility to COPD: Differential Proteomic Profiling after Acute Smoking [Pubmed:25036363] |
| PLoS One | Urine proteome analysis by C18 plate–matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis?… [Pubmed:30024955] |
| Bioscience Reports | N-Acetylcysteine inhalation improves pulmonary function in patients received Liver Transplantation. [Doi: 10.1042/BSR20180858] |
| biorxiv | Mechanical activation of TRPV4 channels controls albumin reabsorption by proximal tubule cells. [] |
| Analytica Chimica Acta | An ultrasensitive electrochemical detection of tryptase using 3D macroporous reduced graphene oxide nanocomposites by one-pot electrochemical synthesis [] |
| Effects of mammary nutrient demand on glucose kinetics of dairy cows in early lactation [] | |
| Biotech Histochem | Role of bone marrow-derived mesenchymal stem cells in alleviating pulmonary epithelium damage and extracellular matrix remodeling in a rat model of lung fibrosis?… [Pubmed: 32909452] |
| OBESITY SURGERY | The Protective Effects of Butorphanol on Pulmonary Function of Patients with Obesity Undergoing Laparoscopic Bariatric Surgery: a Double-Blind Randomized … [Pubmed: 32535786] |
| Respir Res | Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital?… [Pubmed:35189887] |
| Drug Des Devel Ther | Lung-Protective Effects of Lidocaine Infusion on Patients with Intermediate/High Risk of Postoperative Pulmonary Complications: A Double-Blind Randomized?… [Pubmed:35422611] |
留言咨詢
